Skip to main content
. 2021 Nov 5;3(12):699–706. doi: 10.1253/circrep.CR-21-0129

Table 5.

Clinical Characteristics of 73 Patients With Stent Implantation

  Overall Restenosis
No Yes P value
No. patients 73 47 26  
Age (years) 73.7±10.1 75.2±10.2 71.1±9.5 0.101
Male sex 49 (67.1) 27 (57.4) 22 (84.6) 0.021
Hypertension 63 (86.3) 41 (87.2) 22 (84.6) 0.737
Diabetes 32 (43.8) 16 (34.0) 16 (61.5) 0.029
Dyslipidemia 54 (74.0) 39 (83.0) 15 (57.7) 0.026
Hemodialysis 18 (24.7) 8 (17.0) 10 (38.5) 0.052
Prior PCI 30 (41.1) 15 (31.9) 15 (57.7) 0.047
Prior CABG 1 (1.4) 1 (2.1) 0 (0.0) 1
Lesion location (RCA/LMT-LAD/LCX) 43/27/3 23/22/2 20/5/1 0.038
Multivessel disease 59 (80.8) 37 (78.7) 22 (84.6) 0.758
ACS 37 (50.7) 22 (46.8) 15 (57.7) 0.465
Lesion characteristics
 ≥99% stenosis 30 (41.1) 16 (34.0) 14 (53.8) 0.137
 Tortuous 45 (61.6) 26 (55.3) 19 (73.1) 0.209
 Mild/moderate/severe calcification (n) 6/18/49 6/14/27 0/4/22 0.042
Rotational atherectomy 35 (47.9) 26 (55.3) 9 (34.6) 0.142
Drug eluting stent
 Stent size (mm) 3.14±0.37 3.13±0.38 3.16±0.38 0.742
 Stent length (mm) 40.2±18.9 40.9±18.6 39.0±19.8 0.688
 RLA (mm2) 7.41±2.73 7.32±2.70 7.58±2.85 0.706
 MSA (mm2) 6.46±2.37 6.30±2.24 6.77±2.65 0.448
 MSA/RLA 0.88±0.13 0.88±0.13 0.87±0.13 0.855
 Stent eccentricity index 0.78±0.10 0.79±0.10 0.75±0.10 0.088

Data given as mean±SD or numbers (%) unless otherwise mentioned. MSA, minimum stent area; RLA, reference lumen area. Other abbreviations as in Table 3.